Growing Medical Cannabis in Spain – Our Blog and Online Seedbank
Scientists say they have managed to identify the cells that grow into brain tumors and the cells that have the capacity to regenerate after surgery. The same research team has also found a drug that is able to eliminate malignant cells.
This drug is currently in clinical trials here in spain.
The study involved the use of glioma cancer cells. Glioma is the most frequent type of brain tumor.
We would like to give a shout out to the Dinafem seeds company for donating some strains for trials by some of our medical patients. We have received our stock from Dinafem and a selection will be mailed out to patients hopefully by the beginning of next week.
Dinafem Seeds Company
Those keeping journals for us will be emails shortly with all the new website details.
If other growers with medical needs would like to be involved email us at medical@cannabis-spain.com
Seeing as we have our stock from Dinafem we will also be opening their page in the online shop so that you can buy Dinafem seeds as soon as possible.
Remember we have free postage in Europe, first class customer service and only the finest stock of Spanish seeds.
Spain has allowed the medication of medical cannabis derivatives for the treatment of spasticity in patients with multiple sclerosis.
Spain’s health minister Trinidad Jimenez said “the therapeutic use of cannabis has been studied for many years and is well-documented in clinical trials” (The trials that have been allowed that is, evidence has been there for years of course and getting approval in most countries is still difficult.).
The use of cannabis to help with the symptoms of different ailments and medical conditions is a very controversial subject to some (mainly the idiots in power), but what is certain is that some patients with illnesses that involve chronic pain often have turned to medical cannabis to alleviate their suffering.
People diagnosed with multiple sclerosis and experiencing moderate to chronic muscle spasms can get a prescription for the cannabis-based drug, Sativex, which is administered as an oral spray.
The health minister ruled out that the medical use of cannabis will be extended to other ailments, for instance cancer. (At this point now I presume)
She clarified that this was about a very specific use, if other treatments have failed, if and when authorised by a medical specialist and for a very small number of patients. (I suspect that will be a growing list)
Meanwhile, GW Pharmaceuticals the makers of Sativex have begun applying for approval in other European Union member countries Germany, France and Italy.
Marijuana, often called cannabis or marihuana, is considered as one of the most popular types of recreational drugs used today. It includes any number of preparations of the marijuana plant intended for human consumption as a drug, the most common of which is the natural herbal form (the buds) or its derivatives such as hash. (solid resin matter)
The Effects of Marijuana
According to a number of studies across the world, marijuana has been known to cause psychoactive and physiological effects when used. Only about 5 micrograms per pound of human bodyweight of THC (Tetrahydrocannabinol) is needed to have a noticeable psychoactive effect. Along with a subjective change in perception, the most common short-term physical and neurological effects include increased heart rate, lowered blood pressure, impairment to concentration and short-term working memory.
While many drugs clearly fall into the category of either stimulant, depressant, hallucinogen, or antipsychotic, marijuana, containing both THC and CBD, has been cited by many doctors to exhibit a mix of all properties, leaning slightly towards hallucinogen properties due to THC being the dominant active ingredient.
It is Claimed that Trying Marijuana Increases the Probability that Users will Eventually use Harder Drugs!
According to specialists of different cannabis studies into recreational use, the main reason for the theory is that people, upon trying marijuana for the first time and not finding it dangerous, are then tempted to try other, harder drugs. In such a scenario, a new user of marijuana who feels there is a difference between drug information given out by government and their own actual experience of using will apply this distrust to public information about other, more powerful drugs.
Another theory is that while marijuana is not as harmful or addictive as other drugs, a gateway effect may be detected as a result of the “common factors” involved with using any illegal drug. Because of its illegal status, marijuana users are more likely to be in situations which allow them to become acquainted with people who use and sell other illegal drugs.
This hypothesis has been one of the central pillars of anti-marijuana lawmakers in many countries over the last century, though the validity and facts about these statements are highly debated nowadays and looked upon generally as propoganda by most intelligent adults.
